-
公开(公告)号:US20230277556A1
公开(公告)日:2023-09-07
申请号:US18317718
申请日:2023-05-15
申请人: AbbVie Inc.
发明人: Kristof Chwalisz , Jane Castelli-Haley , Oscar Antunez Flores , Keith Gordon , Rita Jain , Juki Wing-Keung Ng , Janine D. North , Charlotte D. Owens , Hannah Palac , Paul M. Peloso , Michael C. Snabes , Ahmed M. Soliman , James W. Thomas , Mohamad Shebley
IPC分类号: A61K31/57 , A61P15/00 , A61K31/513 , A61K31/567
CPC分类号: A61K31/57 , A61P15/00 , A61K31/513 , A61K31/567
摘要: The present invention relates to the method of treating heavy menstrual bleeding in a subject with or without uterine fibroids and in need of treatment by administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens.
-
2.
公开(公告)号:US20230255968A1
公开(公告)日:2023-08-17
申请号:US18168221
申请日:2023-02-13
发明人: Jayanthy Jayanth , Kevin C. Spence , Gregory A. McClelland , Anna V. Stepanenko , Kristof Chwalisz , Charlotte D. Owens , James W. Thomas , Jane Castelli-Haley , Keith Gordon , Michael C. Snabes , Ahmed M. Soliman , Geoff Zhang , David Metzger , Yanxia Li , Tzuchi R. Ju , Xi Shao , Oscar Antunez Flores , Rita Jain , Juki Wing-Keung Ng , Janine D. North , Hannah Palac , Paul M. Peloso
IPC分类号: A61K31/513 , A61K9/20 , A61P5/30 , A61P15/00
CPC分类号: A61K31/513 , A61K9/2009 , A61K9/2018 , A61P5/30 , A61K9/2059 , A61P15/00 , A61K9/2027
摘要: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
-
3.
公开(公告)号:US20190054027A1
公开(公告)日:2019-02-21
申请号:US16105440
申请日:2018-08-20
申请人: AbbVie Inc.
发明人: Yihong Qiu , Yuchuan Gong , Alexander Ruggles , Jared A. Baird , Kristof Chwalisz , Charlotte D. Owens , James W. Thomas , Jane Castelli-Haley , Keith Gordon , Michael C. Snabes , Ahmed M. Soliman , Oscar Antunez Flores , Rita Jain , Juki Wing-Keung Ng , Janine D. North , Hannah Palac , Paul M. Peloso , Laura A. Williams , Hui Zu , Yuerong Hu
IPC分类号: A61K9/20 , A61K31/513 , A61P15/00
摘要: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
-
公开(公告)号:US20210154207A1
公开(公告)日:2021-05-27
申请号:US17047871
申请日:2018-07-23
申请人: AbbVie Inc.
发明人: Kristof Chwalisz , Jane Castelli-Haley , Oscar Antunez Flores , Keith Gordon , Rita Jain , Juki Wing-Keung Ng , Janine D. North , Charlotte D. Owens , Hannah Palac , Paul M. Peloso , Michael C. Snabes , Ahmed M. Soliman , James W. Thomas
IPC分类号: A61K31/57 , A61K31/567 , A61K31/513 , A61P15/00
摘要: The present invention relates to the method of treating heavy menstrual bleeding in a subject with or without uterine fibroids and in need of treatment by administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens.
-
5.
公开(公告)号:US20190054088A1
公开(公告)日:2019-02-21
申请号:US16105396
申请日:2018-08-20
发明人: Jayanthy Jayanth , Kevin C. Spence , Gregory A. McClelland , Anna V. Stepanenko , Kristof Chwalisz , Charlotte D. Owens , James W. Thomas , Jane Castelli-Haley , Keith Gordon , Michael C. Snabes , Ahmed M. Soliman , Geoff Zhang , David Metzger , Yanxia Li , Tzuchi R. Ju , Xi Shao , Oscar Antunez Flores , Rita Jain , Juki Wing-Keung Ng , Janine D. North , Hannah Palac , Paul M. Peloso , Laura A. Williams
IPC分类号: A61K31/513 , A61K9/20 , A61P15/00 , A61P5/30
摘要: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
-
-
-
-